New Study on Dual Use of Cigarettes and E-Cigarettes.

Nov.07.2022
New Study on Dual Use of Cigarettes and E-Cigarettes.
A new study published in the Addiction journal found that dual users of e-cigarettes and combustible cigarettes have lower levels of toxic chemicals.

A new study published in the scientific journal Addiction suggests that individuals who use nicotine vapor products or electronic cigarettes while trying to quit smoking have lower levels of toxic chemicals in their bodies. The study analyzed the biomarkers of nearly 1,300 individuals who either smoked traditional cigarettes, used e-cigarettes, or used both in what is known as dual use. The researchers found that compared to traditional cigarette smokers, those who used both products had lower levels of toxic chemicals such as carbon monoxide in their bodies. This contradicts previous beliefs that using e-cigarettes as a smoking cessation method would lead to increased smoking and greater exposure to harmful chemicals from both traditional and electronic cigarettes.


What is "dual use"? Dual use refers to continuing to smoke traditional cigarettes even after starting to use electronic cigarettes. This has become a common practice among those attempting to quit smoking using electronic cigarettes. Many opponents of electronic cigarettes point to the prevalence of dual use as evidence that electronic cigarettes do not help people quit smoking, but rather encourage the development of another harmful habit: vaping.


It cannot be denied that many people are smoking traditional cigarettes and using e-cigarettes simultaneously. Numerous studies in the past two years have repeatedly found that people attempting to quit smoking by using e-cigarettes continue to smoke traditional cigarettes. Additionally, researchers pointed out that the success rate of dual users quitting either traditional cigarettes or e-cigarettes is not higher than those who use nicotine replacement therapy.


Many studies over the past decade have consistently shown that electronic cigarette users frequently engage in dual use, meaning they continue to smoke traditional tobacco cigarettes while using e-cigarettes. This is the case in the United States, United Kingdom, and European Union. For example, American smokers report that e-cigarette use has remained unchanged for three consecutive years, dropping only slightly from 29.8% in 2015 to 27.7% in 2018.


A similar report exists in the United Kingdom as well. A study revealed that the rate of dual use of electronic and traditional cigarettes is higher among teenagers who only use e-cigarettes, despite them being the largest group in the survey. The research also showed that young people who started with traditional cigarettes are more likely to continue to smoke them even after starting to use e-cigarettes.


Many people from different countries and backgrounds, regardless of race and gender, engage in dual use behavior, which seemed to reinforce the belief that e-cigarettes are not helpful for quitting smoking. However, this new study overturns this assumption by stating that dual use is only a transition, not a permanent one.


Is Dual Use of Tobacco and E-cigarettes Risky? Many studies have hinted at the potential danger of using both tobacco and e-cigarettes simultaneously. For instance, one study suggests that the likelihood of developing cardiovascular diseases is higher in individuals who use both products compared to those who only use e-cigarettes but lower than those who only smoke tobacco. However, new evidence from a recent study reveals the opposite.


A new study has examined the levels of carbon monoxide in the breath of cigarette smokers, e-cigarette users and those who use both. The study found that the levels of carbon monoxide in the bodies of those who only use e-cigarettes were lower than those who smoke cigarettes or use both. However, compared to those who only smoke cigarettes, those who use both also had lower levels of carbon monoxide in their bodies.


Another study found that dual users were more likely to quit smoking after a period of time, rather than returning to using only one type or quitting altogether. However, the study also found that, aside from dual use, there were other factors that caused them to stop smoking, unrelated to whether they smoked cigarettes. This study also suggests that those who smoke cigarettes and use electronic cigarettes usually return to only smoking cigarettes.


Can e-cigarettes help you quit smoking? Despite new research, many public health organizations and policymakers are unlikely to change their views on e-cigarettes, at least in America. However, despite the risks, countries like the UK have already adopted e-cigarettes as another tool to help people quit more harmful smoking habits.


Although this new study does offer new evidence in support of the notion that dual smoking is not as harmful as smoking cigarettes alone, it is not definitive proof. Other factors aside from using electronic cigarettes or vaping are relevant in determining whether an individual can successfully quit smoking. However, this study does indicate that going through a transitional period during the process of quitting smoking is harmless.


Statement:


This article is compiled from third-party information and is intended for industry discussion and learning purposes only.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of its content. The compilation of this article is intended only for industry exchange and research.


Due to limitations in our translation abilities, the translated article may not express the same meaning as the original. Please refer to the original article for accuracy.


Regarding any domestic, Hong Kong, Macao, Taiwan, or foreign-related statements and positions, 2FIRSTS remains fully aligned with the Chinese government.


The compilation of information is the property of the original media and author, and if there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
FDA Authorizes JUUL2, Cites Adult Switching Amid Efforts to Speed PMTA Reviews
The FDA authorized the JUUL2 device and tobacco- and menthol-flavored pods on Aug. 28, bringing the number of authorized e-cigarette products to 48. The agency highlighted complete switching among adult smokers, with six-week switching rates reaching 28.4%–49.3% for the menthol pod. The decision comes as FDA works to speed PMTA reviews, reduce application backlogs and expand authorized e-cigarette and nicotine-pouch products while maintaining enforcement priorities for unauthorized products.
Regulations
Aug.29
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
Australia’s One Nation Proposes 75% Tobacco Tax Cut, Says Lower Prices Could Hit Illicit Market
Australia’s One Nation Proposes 75% Tobacco Tax Cut, Says Lower Prices Could Hit Illicit Market
Australia’s One Nation party has proposed cutting tobacco excise by 75%, arguing that lower legal cigarette prices could narrow the gap with illicit tobacco and reduce demand for black-market products. The proposal comes as Australia continues expanding enforcement against illicit tobacco supply chains through border controls, retail inspections and organised-crime investigations. Supporters argue high taxes have contributed to illicit-market growth, while opponents warn that lower tobacco prices could undermine public-health goals. The proposal is a party policy position and has not been adopted by the Australian government.
Aug.18
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24